Sanara MedTech Inc.
SMTI
$24.44
$0.301.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 42.51% | -99.93% | -548.65% | -- |
| Total Depreciation and Amortization | -- | 0.79% | 1.72% | 0.62% | -- |
| Total Amortization of Deferred Charges | -- | -24.85% | 1,812.90% | 1,812.90% | -- |
| Total Other Non-Cash Items | -- | 41.22% | 166.24% | 193.20% | -- |
| Change in Net Operating Assets | -- | 159.43% | -21.23% | 150.92% | -- |
| Cash from Operations | -- | 288.68% | -25.37% | 209.84% | 92.70% |
| Capital Expenditure | -- | -2,895.58% | -2,517.93% | -32.97% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -6,580.27% | -7,772.19% | -139.41% | 37.14% |
| Total Debt Issued | -- | -100.31% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -662.82% | 88.16% | -1,791.18% | -- |
| Cash from Financing | -- | -151.43% | 1,919.72% | -545.99% | 56.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -212.25% | 307.40% | 63.36% | 5,663.69% |